Gene Panel Market to grow by USD 5403.9 million between 2024-2028
According to a research report “ Gene Panel Market” by Product (Small panel testing, Large panel testing) Technique (Amplicon, Hybridization) Geography (North America, Europe, Asia, Rest of World (ROW))- Global Forecast to 2028 published by Technavio, the market size is estimated to grow by USD 5403.9 million at a CAGR of almost 23.44% during the forecast period. In the burgeoning gene panel market, the significance of gene panels in crafting targeted therapies for cancer is increasingly recognized. Pharmaceutical firms are pouring substantial resources into research and development of these therapies, given the escalating demand for effective cancer treatments. With numerous solid tumors attributed to gene mutations, conventional therapies offer only temporary relief. To cater to this unmet need, the market has seen the integration of clinically relevant target sequences into Next-Generation Sequencing (NGS) based gene panel assays..
Browse market data tables, figures, and in-depth TOC on “Gene Panel Market” by Product (Small panel testing, Large panel testing) Technique (Amplicon, Hybridization) Geography (North America, Europe, Asia, Rest of World (ROW)) Global Forecast to 2028.
View detailed Table of Content- Click here
By Product, the Small panel testing segment is projected to dominate the market size in 2024.
In the dynamic business landscape, the Gene Panel Market holds significant potential for growth. This market encompasses a range of diagnostic tools utilizing multiple genes for identifying genetic disorders and predicting disease risks. By providing comprehensive genetic information, these panels enable personalized treatment plans and improved patient outcomes. The market's expansion is driven by increasing awareness of genetic disorders, technological advancements, and regulatory support.
By Technique, Amplicon segment is expected to hold the largest market size for the year 2024.
In the dynamic business landscape, the Gene Panel Market holds significant potential for growth. This market encompasses a range of diagnostic tools utilizing multiple genes for identifying genetic disorders and predicting disease risks. By providing comprehensive genetic information, these panels enable personalized treatment plans and improved patient outcomes. The market's expansion is driven by increasing awareness of genetic disorders, technological advancements, and regulatory support.
North America is forecasted to hold the largest market size by region in 2024.
In the dynamic business landscape, the Gene Panel Market holds significant potential for growth. This market encompasses a range of diagnostic tools utilizing multiple genes for identifying genetic disorders and predicting disease risks. By providing comprehensive genetic information, these panels enable personalized treatment plans and improved patient outcomes. The market's expansion is driven by increasing awareness of genetic disorders, technological advancements, and regulatory support.
The Gene Panel Market growth and forecasting report also includes detailed analyses of the competitive landscape of the market growth and forecasting and information about 20 market companies, including:
.
For insights on company offerings- Request a sample report!
Research Analysis Overview
In the realm of personalized medicine, the gene panel market holds significant importance in addressing the complexities of multiple chronic conditions among adults. These conditions encompass various therapeutic areas such as arthritis, diabetes, cardiovascular diseases, and oncology. Genetic composition plays a crucial role in disease prognostics and mortality rates, making genetic testing essential. Gene panels, a subset of genetic testing, enable the identification of genetic alterations linked to hereditary disorders, including monogenic defects and diagnosed genetic conditions. Genomics and sequencing technologies facilitate the analysis of genes and gene panels, providing valuable insights into genetic predisposition and cancer rates. Clinicians utilize this information to tailor therapeutics and improve patient outcomes. Gene panels are instrumental in the diagnosis and management of genetic disorders, ultimately contributing to the advancement of disease-specific therapeutics and disease prevention strategies.
Market Research Overview
The Gene Panel Market encompasses a range of diagnostic services and test kits designed to identify genetic information related to multiple chronic conditions, including Arthritis, Diabetes, and Cardiovascular diseases. These panels employ Next-Generation Sequencing (NGS), Cancer Panels, Pharmacogenomic Panels, Carrier Screening Panels, and Diagnostic Panels to provide evidence of clinical value for adults. Insurance coverage and reimbursement policies vary, and laboratories strive for standardization to ensure accurate data analysis. Gene panels are essential in the context of personalized medicine, as they help assess cancer rates and identify genetic alterations associated with hereditary diseases. Oncology and genetics play a significant role in the development and implementation of these panels. HLA typing and methylation microarray are among the genomic technologies used in gene panel testing. Customizable and pre-designed gene panels cater to various therapeutic regimes and prognostic steps, allowing clinicians to make informed decisions based on genetic predisposition and risk factors. Early screening for monogenic defects and diagnosed genetic conditions is crucial for disease prognostics and mortality rate reduction. Gene panels are also used in the context of transplants, such as bone marrow and organ transplants, and in the diagnosis of rare disorders.
Contacts
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/
